Investigating Factors that Worsen Diabetes Care in the U.S.
“In the past two years, we’ve all been faced with multiple challenges from the COVID-19 pandemic to rising health inequities,”…
How a Person’s Race & Ethnicity Affect their T1D Care
How T1D Exchange is Improving Care for People with Type 1 Diabetes
While you’re probably familiar with diabetes research related to getting new types of insulin or medications approved, you may not…
Improve Life with Diabetes by Participating in Research
Your voice matters. Often the biggest changes in anything are the result of something initially small. People with diabetes are…
4 Things to Consider When Choosing a Health Insurance Plan
Finding and choosing a health insurance plan for an individual or a family faced with the medical demands and costs…
Breaking Down the Science: How We Make Change Happen
Emily’s Story: Using Nasal Glucagon to Treat Severe Hypoglycemia
Emily Marcum was excited to take her parents, John and Andrea, on a 10-mile walking tour of Manhattan and Brooklyn…
Breaking Down the Science: The T1D Exchange Health Equity Advancement Lab Program
With so much data being gathered during the pandemic, COVID-19 research has revealed the glaring severity of healthcare inequities in…
Breaking Down the Science: The T1D and COVID-19 Surveillance Study
In March of 2020, T1D Exchange quickly recognized — along with the rest of the country — that COVID-19 was…
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
